DR. PARVEZ ANSARI

PROF.APARAJITA CHAUDHARY, DR. KAMALJEET SINGH, DR.DR. SANTOSH I KUMAR

Abstract

AIM: To determine role of 0.01% topical Atropine eyedrop for slowing progression of myopia in Pediatric age group.

METHODS: In this prospective observational study, 168 eyes of 84 myopic children aged 6 to 18 years with progressive increase of ≥ -0.5D sphere/year were treated with bedtime application of 0.01% atropine eye drop. Change in refractive error, change in axial length and safety of the eyedrop were analyzed at 3rd, 6th, 9th and 12th month.

RESULTS: Mean spherical equivalent before treatment was -2.22D and after 1 year of treatment was -2.58D. Myopia progression was reduced to -0.36D/yr. Mild headache was observed in 4 cases (4.76%) and sensitivity to light was seen in 4 cases (4.76%). Pre treatment axial length was 24.319 mm and after 1 year of treatment was 24.492 mm. i.e. 0.173mm/yr change in axial length was seen.

CONCLUSION: 0.01% atropine eye drop is effective in slowing progression of myopia with minimal adverse effects.